Tender Overview
The opportunity is issued by the Indian Army under the Department of Military Affairs for a broad range of medical and allied items, including tablets (e.g., Levodopa, Gabapentin, Ropinirole), analgesics (Naproxen combination with domperidone), anxiolytics/antidepressants, anti-Parkinson and anti-epileptic drugs, as well as mobility aids like walking sticks and analgesic ointments. Estimated value is ₹283,895.40 for the package comprising 17 total items listed in the BOQ, located in UDHAMPUR, JAMMU & KASHMIR 182101. The tender emphasizes non-obsolescence with a minimum market life of 3 years for quoted products and a shelf-life requirement of at least 60% remaining life at the time of supply. Bidders must meet government procurement criteria, provide OEM authorization where applicable, and be prepared for quantity variations up to 50% under the option clause. The tender requires compliance with GST norms and supplier due-diligence on financial standing and sanctions.
Technical Specifications & Requirements
- Product categories: pharmaceutical tablets (e.g., Levodopa+Carbidopa, Gabapentin, Ropinirole), assorted analgesics and mood stabilizers, combination ointments, and mobility aids (walking sticks).
- Estimated value: ₹283,895.40; no explicit unit price per item in BOQ.
- Shelf life: minimum 5/6 shelf life required on supply date.
- Key terms: non-obsolete items, OEM authorization where applicable, and 3-year residual market life.
- Delivery/qualification: products to be supplied to a defence buyer; ensure regulatory compliance and EMD status (if applicable).